UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting

International journal of cancer, 2021-03, Vol.148 (5), p.1208-1218

2021

Volltextzugriff (PDF)

Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

BMC cancer, 2018-08, Vol.18 (1), p.784-784, Article 784

2018

Volltextzugriff (PDF)

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

BMJ open, 2022-04, Vol.12 (4), p.e054258-e054258

2022

Volltextzugriff (PDF)

Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment

Clinical and translational gastroenterology, 2020-09, Vol.11 (9), p.e00239-e00239

2020

Volltextzugriff (PDF)

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial

BMC gastroenterology, 2023-01, Vol.23 (1), p.7-7, Article 7

2023

Volltextzugriff (PDF)

Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms

Histopathology, 2017-01, Vol.70 (2), p.203-210

2017

Volltextzugriff (PDF)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study

EClinicalMedicine, 2022-11, Vol.53, p.101664, Article 101664

2022

Volltextzugriff (PDF)

Targeted Screening for Barrett’s Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.167 (4), p.798-800.e4

2024

Volltextzugriff (PDF)

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens

Gut, 2018-11, Vol.67 (11), p.1942

2018

Volltextzugriff (PDF)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

The Lancet (British edition), 2020-08, Vol.396 (10247), p.333-344

2020

Volltextzugriff (PDF)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

The lancet oncology, 2022-02, Vol.23 (2), p.270-278

2022

Volltextzugriff (PDF)

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients

Clinical gastroenterology and hepatology, 2019-03, Vol.17 (4), p.647-656.e1

2019

Volltextzugriff (PDF)

Sa1147 – Analysis of Socio-Economic Factors Affecting the Uptake of the Novel Medical Device Cytosponge

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-284-S-285

2019

Volltextzugriff (PDF)

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM

Frontline gastroenterology, 2022-10, Vol.14 (4), p.355-356

2022

Volltextzugriff (PDF)

634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-136-S-136

2020

Volltextzugriff (PDF)

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM

Frontline gastroenterology, 2023-07, Vol.14 (4), p.355-356

2023

Volltextzugriff (PDF)

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic

The lancet. Gastroenterology & hepatology, 2020-09, Vol.5 (9), p.805-806

2020

Volltextzugriff (PDF)

Safety and acceptability of a non-endoscopic esophageal sampling device – Cytosponge®: a systematic review of multi-center data

Clinical gastroenterology and hepatology, 2018-08, Vol.17 (4), p.647-656.e1

2018

Volltextzugriff (PDF)

Breath Biopsy ® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection

Journal of clinical and translational hepatology, 2023-06, Vol.11 (3), p.638-648

2023

Volltextzugriff (PDF)

Barrett's oESophagus trial 3

BMC cancer, 2018-08, Vol.18 (1)

2018

Volltextzugriff (PDF)

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study

The lancet. Gastroenterology & hepatology, 2017-01, Vol.2 (1), p.23-31

2017

Volltextzugriff (PDF)

54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-16-S-16

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting

Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study

Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial

Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study

Targeted Screening for Barrett’s Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma

Sa1147 – Analysis of Socio-Economic Factors Affecting the Uptake of the Novel Medical Device Cytosponge

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM

634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic

Safety and acceptability of a non-endoscopic esophageal sampling device – Cytosponge®: a systematic review of multi-center data

Breath Biopsy ® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection

Barrett's oESophagus trial 3

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study

54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus

Suchergebnisse filtern